By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Coherus Biosciences 

201 Redwood Shores Parkway
Suite 200
Redwood City  California  94065  U.S.A.
Phone: 800-794-5434 Fax: n/a



Company News
Coherus To Report Second Quarter 2015 Financial Results On August 10 7/28/2015 8:26:16 AM
Coherus To Present At Jefferies and Co. Healthcare Conference On June 3 5/27/2015 7:21:38 AM
Coherus To Report First Quarter 2015 Financial Results On May 11 5/4/2015 11:11:28 AM
Coherus To Present At Deutsche Bank (DB) Health Care Conference On May 7 4/30/2015 11:08:28 AM
Coherus And Baxter International (BAX) Announce Amendment To Etanercept Biosimilar Collaboration Agreement 4/15/2015 7:22:51 AM
Fidelity CEO Uses Personal Fortune to Bet on Cancer Related IPOs Like Coherus, Adaptimmune and Blueprint Medicines 4/10/2015 6:06:18 AM
Coherus Biosciences Prices Upsized Public Offering Of $120.0 Million Of Common Stock 4/1/2015 6:41:21 AM
Coherus Biosciences Announces Proposed Public Offering Of Common Stock 3/30/2015 3:16:40 PM
Coherus Biosciences Reports Fourth Quarter And Year End 2014 Financial And Operating Results 3/24/2015 8:33:05 AM
Coherus Biosciences Finalizes CHS-1701 BLA Enabling Clinical Program And Initiates Pivotal Pharmacokinetic And Pharmacodynamic Study 3/17/2015 7:29:31 AM